Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

La-Z-Boy Incorporated Common Stock (NY: LZB )

38.33 -1.43 (-3.60%)
Official Closing Price Updated: 6:30 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about La-Z-Boy Incorporated Common Stock

< Previous 1 2 3 4 5 6 Next >
La-Z-Boy's Earnings: A Preview
Via Benzinga
Wayfair Still Has Its Fair Share of Issues
It may seem tempting to declare Wayfair a potential 2023 turnaround story, but plenty of headwinds remain - including a slowdown in U.S. e-commerce activity. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
The Institutions Are Comfortable With The Furniture Industry
Furniture stocks are tightly held names that are still offering value and yield to investors, and they are outperforming expectations. 
Via MarketBeat
Ranking the 7 Top Small-Cap Stocks to Buy From Best to Worst
Although blue chips provide greater predictability, these top small-cap stocks to buy may drive intense growth for speculators. 
Via InvestorPlace
These REITs With Yields Higher Than The Risk-Free Rate May Hedge Against Inflation
Real estate investment trusts (REITs) have been beaten down since the start of the year, but now may be the perfect time to open a position in one. 
Via Benzinga
La-Z-Boy Stock Surges Post Q4 Earnings Beat, Guides Q1 Sales Above Consensus
La-Z-Boy Incorporated (NYSE: LZB) reported 
Via Benzinga
Sidoti's September Small-Cap Virtual Conference
Via ACCESSWIRE
La-Z-Boy's Return on Invested Capital Insights
According to Benzinga Pro, during Q1, La-Z-Boy (NYSE:LZB) earned $38.94 million, a 32.42% increase from the preceding quarter. La-Z-Boy's sales decreased to $604.09 million, a 11.76% change since Q4. 
Via Benzinga
Monday Is Your Last Chance To Buy La-Z-Boy Before The Dividend Payout
Monday marks the last chance for investors to receive the next dividend payout from La-Z-Boy (NYSE:LZB). 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Earnings Scheduled For August 23, 2022
Companies Reporting Before The Bell • Regis (NYSE:RGS) is estimated to report earnings for its fourth quarter. • Jianpu Technology (NYSE:JT) is likely to report earnings for its second quarter. 
Via Benzinga
Earnings Outlook For La-Z-Boy
La-Z-Boy (NYSE:LZB) is set to give its latest quarterly earnings report on Tuesday, 2022-08-23. Here's what investors need to know before the announcement. Analysts estimate that La-Z-Boy will report... 
Via Benzinga
Why Shares Of La-Z-Boy Are Trading Higher Today
La-Z-Boy Inc. (NYSE: LZB) shares are trading higher after the company reported better-than-expected fourth quarter EPS and sales results. The company also issued 2023 first quarter sales guidance. 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash. 
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash. 
Via Benzinga
The Stock Market Had a Good Day on Tuesday as Wall Street Makes a Comeback, and the Markets Are Rallying.
Market participants were once again concerned that the Federal Reserve's ambitious intentions to tighten monetary policy may push the United 
Via Best Stocks
Topics Economy Stocks
Exposures Economy Interest Rates US Equities
Futures, Oil Tumble As Attention Turns To Coming Recession, Powell Senate Testimony
Tuesday's euphoric market mood has U-turned into sheer despair with most of yesterday's gains gone overnight as attention turns to the coming US recession. 
Via Talk Markets
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday. 
Via Benzinga
US Stock Futures Down; Powell Testimony In Focus
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones gained more than 600 points in the previous session. 
Via Benzinga
5 Stocks To Watch For June 22, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
11 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Tuesday's Market Minute: A Busy Week to Come
Here are a few things to keep an eye on that could move markets. First, we begin the week with global industries higher, bouncing back from last week’s sell-off. The move comes in reaction to President... 
Via Benzinga
Earnings Scheduled For June 21, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its first quarter. 
Via Benzinga
5 Stocks To Watch For June 21, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
13 Undervalued Stocks
Even though the stock market appears to be correcting recently, the overall market still trades at historically high valuations. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
56 Biggest Movers From Yesterday
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.